1 |
Anxiously, M., Pohjanvirta, R., Honkakoski, P., Torronen, R., and Tuomisto, J. 2,3,7,8-Tetrachlorodibenzo--dioxin (TCDD) induced ethoxyresorufin-O-deethylase (EROD) and aldehyde dehydrogenase (ALDH3) activities in the brain and liver. A comparison between the most TCDD-susceptible and the most TCDD-resistant rat strain. Biochem. Pharmacol., 46, 651-659 (1993)
DOI
ScienceOn
|
2 |
Cashman, J. R. and Hanzlik, R. P. Microsomal oxidation of thiobenzamide: A photometric assay for the flavin-containing monooxygenase. Biochem. Biophys. Res. Commun., 98, 147-153 (1981)
DOI
ScienceOn
|
3 |
Chesney, C. F. and Allen, J. R. Resistance of the guinea pig to pyrrolizidine alkaloid intoxication. Toxicol. Appl. Pharmacol., 26,385-392 (1973)
DOI
ScienceOn
|
4 |
Debessae, W. T., Huan, J., and Cheeke, P. R., Interactions in sheep between tall fescue ergot alkaloids and hepatotoxic carbon tetrachloride and Senecio pyrrolizidine alkaloids. Vet. Hum. Toxicol., 41, 129-133 (1999)
PUBMED
|
5 |
Guo, Z., Raeissi, S., White, R. B., and Stevens, J. C., Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metab Dispos., 25, 390-393 (1997)
|
6 |
Kedzierski, B. and Buhler, D. R., Method for determination of pyrrolizidine alkaloids and their metabolites by high-performance liquid chromatography. Anal. Biochem., 152, 59-65 (1986)
DOI
ScienceOn
|
7 |
Kulkarni, S. G., Warbritton, A., Bucci, T. J., and Mehaendale, H. M.m Antimitotic intervention with colchicine alters the outcome of o-DCB-induced hepatotoxicity in Fischer 344 rats. Toxicology, 27, 79-88 (1997)
|
8 |
Mattocks, A. R. and Bird, I., Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity. Chem. Biol. Interact., 43, 209-222 (1983)
DOI
ScienceOn
|
9 |
Steenkamp, V., Stewart, M. J., van der Merwe, S., Zuckerman, M., and Crowther, N. J., The effect of Senecio latifolius, a plant used as a South African traditional medicine, on a human hepatoma cell line. J. Ethnopharmacol., 78, 51-58 (2001)
DOI
ScienceOn
|
10 |
White, I. N. H., Mattocks, A. R., and Butler, W. H., The conversion of the pyrrolizidine alkaloid retrorsine to pyrrolic derivatives in vivo and in vitro and its acute toxicity to various animal species. Chem. Biol. lnteract., 6, 207-218 (1973)
DOI
ScienceOn
|
11 |
Williams, D. E., Reed, R. L., Kedzierski, B., Ziegler, D. M., and Buhler, D. R., The role of flavin-containing monooxygenase in the N-oxidation of the pyrrolizidine alkaloid senecionine. Drug Metab. Dispos., 17, 380-386 (1989b)
|
12 |
Simon, B., De Looze, S., Ronai, A., and Von Deimling, O., Identification of rat liver carboxylesterase isozymes (EC 3.1.1.1) using polyacrylamide gel electrophoresis and isoelectric focusing. Electrophoresis, 6, 575-582 (1985)
DOI
|
13 |
Huan, J. Y., Miranda, C. L., Buhler, D. R., and Cheeke, P. R., Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids. Toxicol. Lett. 99, 127-137 (1998)
DOI
ScienceOn
|
14 |
Roeder, E., Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie, 55, 711-726 (2000)
PUBMED
|
15 |
Larsen-Su, S. and Williams, D. E., Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing monooxygenase form 1 in rat liver and intestine. Drug Metab. Dispos., 24, 927-931 (1996)
|
16 |
Lawton, M. P. and Philpot, R. M., Functional characterization of flavin-containing monooxygenase 1B1 expressed in Saccharomyces cerevisiae and Escherichia coli and analysis of proposed FAD- and membrane-binding domains. J. Bioi. Chem., 268, 5728-5734 (1993b)
PUBMED
|
17 |
Miranda, C. L., Reed, R. L., Guengerich, F. P., and Buhler, D R., Role of cytochrome P450 IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver. Carcino-genesis, 12, 515-519 (1991b)
DOI
ScienceOn
|
18 |
Chung, W. G. and Buhler, D. R., The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionineby hepatic microsomes from rats and guinea pigs. Toxicol. Appl. Pharmacol., 127, 314-319 (1994)
DOI
ScienceOn
|
19 |
Miranda, C. L., Chung, W. G., Reed, R. L., Zhao, X., Henderson, M. C., Wang, J. L., Williams, D. E., and Buhler, D. R., Flavin-containing monooxygenase: A major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues. Biochem. Biophys. Res. Commun., 178, 546-552 (1991a)
DOI
ScienceOn
|
20 |
Chung, W. G., Miranda, C. L., and Buhler, D. R., A cytochrome P4502B form is the major bioactivation enzyme for the pyrrolizidine alkaloid senecionine in guinea pig. Xenobiotica 25, 929-939 (1995)
DOI
ScienceOn
|
21 |
Ziegler, D. M., Recent studies on the structure and function of multisubstrate flavin-containing monooxygenase. Annu. Rev. Pharmacol. Toxicol., 33, 179-199 (1993).
DOI
PUBMED
ScienceOn
|
22 |
Mattocks, A. R., Chemistry and toxicology of pyrrolizidine alkaloids. Academic Press, New York (1986)
|
23 |
Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., and Kaminsky, L. S., Purification and characterization of microsomal cytochrome P450s. Xenobiotica, 12, 701-716 (1982)
DOI
ScienceOn
|
24 |
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951)
PUBMED
|
25 |
Stegelmeier, B. L., Edgar, J. A., Colegate, S. M., Gardner, D. R., Schoch, T. K., Coulombe, R. A., and Molyneux, R. J. Pyrrolizidine alkaloid plants, metabolism and toxicity. J. Nat. Toxins, 8, 95-116 (1999)
PUBMED
|
26 |
Waxman, D. J., Rat hepatic cytochrome P-450 isoenzyme 2c. J. Biol. Chem., 259, 15481-15490 (1984)
PUBMED
|
27 |
Nagata, T., Williams, D. E., and Ziegler, D. M. Substrate specificities of rabbit lung and porcine liver flavin-containing monooxygenase: difference due to substrate size. Chem. Res. Toxicol., 3, 372-376 (1990)
DOI
ScienceOn
|
28 |
Ziegler, D. M., Flavin-containing monooxygenase: catalytic mechanism and substrate specificities. Drug Metab. Rev., 19, 1-32 (1988)
DOI
PUBMED
ScienceOn
|
29 |
Sato, R. and Omura, T., Cytochrome P450. Academic Press, New York, p233 (1978)
|
30 |
Tsokos-Kuhn, J. O., Lethal injury by diquat redox cycling in an isolated hepatocyte model. Arch. Biochem. Biophys., 265, 415-424 (1988)
DOI
PUBMED
ScienceOn
|
31 |
Coulombe, R. A. Jr., Pyrrolizidine alkaloids in foods. Adv. Food Nutr. Res., 45, 61-99 (2003)
DOI
ScienceOn
|
32 |
Pan, L. C., Wilson, D. W., and Segall, H. J., Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease. Toxicology, 79, 21-35 (1993)
DOI
ScienceOn
|
33 |
Wood, A. W., Ryan, D. E., Thomas, P. E., and Levin, W., Regio- and stereo-selective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P450 isozymes. J. Biol. Chem., 258, 8839-8847 (1986)
|
34 |
Augustine, J. A. and Zemaitis, M. A. A comparison of the effects of cyclosporine on the hepatic microsomal drug metabolism in three different strains of rat. Gen. Pharmacol., 20, 137-141 (1989)
DOI
PUBMED
ScienceOn
|
35 |
Lawton, M. P. and Philpot, R. M., Molecular genetics of flavin-dependent monooxygenases. Pharmacogenetics, 3, 40-44 (1993a)
DOI
ScienceOn
|
36 |
Chou, M. W., Wang, Y. P., Yan, J., Yang, Y. C., Beger, R. D., Williams, L. D., Doerge, D. R., and Fu, P. P. Riddellineoxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelline. Toxicol. Lett., 145, 239-247 (2003)
DOI
ScienceOn
|
37 |
Koster, A. S., Nieuwenhuis, L., and Frankhuijzen-Sierevogel, A. C., Comparison of microsomal drug-metabolizing enzymes in 14 rat inbred strains. Biochem. Pharmacol., 38, 759-765 (1989)
DOI
ScienceOn
|
38 |
Omura, R. and Sato, T., The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2374 (1964)
PUBMED
|
39 |
Chung, W. G. and Buhler, D. R., Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine. Drug Metab. Dispos., 23, 1263-1267 (1995)
|
40 |
Arseculeratne, S. N., Gunatilaka, A. A., and Panabokke, R. G. Toxicity of some traditional medicinal herbs. J. Ethnopharmacol., 13, 323-335 (1985)
DOI
ScienceOn
|
41 |
Rampersaud, A. and Walz, F. G., Polymorphisms of four hepatic cytochrome P450 in twenty-eight inbred strains of rat. Biochem. Gen., 25, 527-534 (1987)
DOI
ScienceOn
|
42 |
McLean, E. K., The toxic actions of pyrrolizidine (Senecio) alkaloids. Pharmacol. Rev. 22, 249-483 (1970)
PUBMED
|
43 |
Noller, B. N., Myers, S., Abegaz, B., Singh, M. M., Dronenberg, F., and Bodeker, G. Global forum on safety of herbal and traditional medicine: July 7, 2001, Gold Coast, Australia. J. Altern. Complement. Med., 7, 683-601 (2001)
DOI
ScienceOn
|
44 |
Williams, D. E., Reed, R. L., Kedzierski, B., Dannan, G. A., Guengerich, F. P., and Buhler, D. R., Bioactivation and detoxification of the pyrrolizidine alkaloid senecionine by cytochrome P450 enzymes in rat liver. Drug Metab. Dispos., 17, 387-392 (1989a)
|
45 |
White, I. H. N. and Mattocks, A. R., Reaction of dihyropyrrolizines with deoxyribonucleic acids in vitro. Biochem. J., 129, 291-297 (1972)
|